Trial identifies five-drug combo for ‘ultra high risk’ bone marrow cancer 12 Dec 2021 A combination of five existing drugs keeps cancer at bay for longer in patients with a highly aggressive type of bone marrow cancer, a major new trial reveals. Find out more Show/Hide